Is Evidence-based Medicine being hijacked in oncology?
My talk delivered to Consilium Scientific on August 26th, 2021#oncology #evidence-based medicine #surrogate #endpoints #crossover #RCT
My talk delivered to Consilium Scientific on August 26th, 2021#oncology #evidence-based medicine #surrogate #endpoints #crossover #RCT
Days after they were born, Eli and Easton Reed were diagnosed with spinal muscular atrophy.
ACC President Cathie Biga, MSN, FACC launched her “Heart Talk with Cathie” presidential discussion live from MedAxiom’s CVTransforum in Atlanta. With the hel…
Chromoplexy is detectable using targeted NGS in a substantial portion of EWSR1-rearranged round cell sarcomas as an early and persistent clonal event, expanding the genomic…
Adding ibrutinib to first-line treatment resulted in superior efficacy in younger mantle cell lymphoma patients with increased toxicity when given after ASCT. Adding ibrutinib during…
But are they really such a good idea? May 02, 2024 It takes a certain amount of confidence to call your biotech company Grail. According…
Nature Communications – Bavituximab is a genetically engineered IgG1 chimeric antibody that targets phosphatidylserine. Here the authors report the results of a single-arm phase 2…
Little House on the Prairie’s Michael Landon passed away in 1991 at age 54, but his children continue to feel his presence. “My father is…
Original source: https://www.c-span.org/video/?125856-1/greenhouse-effectDECEMBER 10, 1985“Witnesses testified on how the greenhouse effect will change the g…
Nature Communications – CAR T cell immunotherapy for paediatric solid and brain tumours is constrained by the availability of targetable antigens. Here, the authors investigate…
There are no effective approaches to overcome the immunosuppressive activity of tumor-associated macrophages (TAMs). De Leo et al. report that monocyte-derived macrophages (MDMs), but not microglia…